Stock listing

OTC:AXIM Axim Biotechnologies, Inc. Stock

Follow Axim Biotechnologies, Inc. into a list and get an email when it puts out news.

Share price · OTC:AXIM

$0.0031 USD -0.0001 (-3.1%)

Close on Nov 2, 2026

Past year -63.5% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$0.0031 – $0.0031 USDNov 2, 2026
Volume
41,000 sharesNov 2, 2026
Market cap
$1.08M USDAt the close on Nov 2, 2026 · price × 349.8M shares outstanding
52-week range
$0.0020 – $0.0290 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$1,200 USDMedian day 169,000 shares · 2 days with no trades · last 3 months, Aug 3, 2026 – Nov 2, 2026
Axim Biotechnologies, Inc. logo

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OTC:AXIM · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0031-0.0001-3.1%$0.0031$0.0031$0.003141,000
$0.0032-0.0001-3.0%$0.0032$0.0032$0.0032100,033
$0.0033+0.0002+6.5%$0.0030$0.0033$0.003032,176
$0.0031+0.0001+3.3%$0.0032$0.0032$0.003151,150
$0.0030-0.0002-6.3%$0.0030$0.0030$0.003012,200
$0.0032+0.0002+6.7%$0.0032$0.0032$0.003210,000
$0.00300.00000.0%$0.0030$0.0030$0.00301,644
$0.00300.00000.0%$0.0030$0.0030$0.0030248,600
$0.00300.00000.0%$0.0030$0.0030$0.0030373,600
$0.00300.00000.0%$0.0030$0.0030$0.003046,000
$0.00300.00000.0%$0.0030$0.0030$0.0030196,300
$0.00300.00000.0%$0.0030$0.0030$0.00300
$0.00300.00000.0%$0.0030$0.0030$0.0030196,000
$0.00300.00000.0%$0.0030$0.0030$0.0030287,700
$0.00300.00000.0%$0.0030$0.0030$0.0030400,500
$0.00300.00000.0%$0.0030$0.0030$0.00305,000
$0.00300.00000.0%$0.0030$0.0030$0.0030200,200
$0.0030-0.0010-25.0%$0.0030$0.0040$0.003012,300
$0.0040+0.0005+14.3%$0.0040$0.0040$0.0040173,700
$0.0035+0.0001+2.9%$0.0034$0.0035$0.0033166,331
$0.0034+0.0004+13.3%$0.0033$0.0034$0.00331,410
$0.0030-0.0010-25.0%$0.0040$0.0040$0.0030139,400
$0.0040+0.0010+33.3%$0.0030$0.0040$0.003075,200
$0.0030-0.0007-18.9%$0.0040$0.0040$0.003013,300
$0.00370.00000.0%$0.0035$0.0037$0.0033652,606
$0.0037-0.0003-7.5%$0.0037$0.0037$0.003740,071
$0.00400.00000.0%$0.0040$0.0040$0.0040300
$0.00400.00000.0%$0.0040$0.0040$0.004020,500
$0.0040+0.0002+5.3%$0.0030$0.0040$0.0030238,800
$0.0038+0.0004+11.8%$0.0037$0.0038$0.0037200
$0.0034-0.0006-15.0%$0.0034$0.0034$0.00341,895
$0.00400.00000.0%$0.0040$0.0040$0.00400
$0.00400.00000.0%$0.0030$0.0040$0.0030502,100
$0.00400.00000.0%$0.0040$0.0040$0.0030152,100
$0.00400.00000.0%$0.0040$0.0040$0.004080,200
$0.00400.00000.0%$0.0040$0.0040$0.00401,364,900
$0.00400.00000.0%$0.0040$0.0040$0.0040134,100
$0.00400.00000.0%$0.0040$0.0040$0.004059,200
$0.00400.00000.0%$0.0040$0.0040$0.004094,400
$0.00400.00000.0%$0.0040$0.0040$0.004057,600
$0.00400.00000.0%$0.0040$0.0040$0.0040206,500
$0.00400.00000.0%$0.0040$0.0040$0.004030,300
$0.00400.00000.0%$0.0040$0.0040$0.0040176,300
$0.00400.00000.0%$0.0040$0.0040$0.0030629,100
$0.00400.00000.0%$0.0040$0.0040$0.0040192,300
$0.0040+0.0010+33.3%$0.0040$0.0040$0.0030194,400
$0.00300.00000.0%$0.0030$0.0030$0.003020,100
$0.0030-0.0003-9.1%$0.0040$0.0040$0.0030169,000
$0.0033-0.0003-8.3%$0.0035$0.0039$0.0033451,341
$0.0036+0.0006+20.0%$0.0036$0.0036$0.0035227,335
$0.00300.00000.0%$0.0030$0.0040$0.0030235,800
$0.00300.00000.0%$0.0030$0.0040$0.0030868,300
$0.0030-0.0010-25.0%$0.0040$0.0040$0.0030876,600
$0.0040-0.0010-20.0%$0.0040$0.0040$0.0030616,500
$0.00500.00000.0%$0.0050$0.0050$0.0050362,700
$0.00500.00000.0%$0.0040$0.0050$0.0040956,000
$0.00500.00000.0%$0.0050$0.0050$0.0050278,000
$0.0050+0.0001+2.0%$0.0050$0.0060$0.0050607,100
$0.0049+0.0019+63.3%$0.0031$0.0052$0.00304,190,787
$0.00300.00000.0%$0.0025$0.0030$0.0025158,412
$0.00300.00000.0%$0.0030$0.0030$0.0030635,300
$0.00300.00000.0%$0.0030$0.0030$0.00301,026,100
$0.0030-0.0001-3.2%$0.0030$0.0030$0.0030338,000
$0.0031+0.0004+14.8%$0.0028$0.0031$0.0027233,375
$0.0027-0.0003-10.0%$0.0027$0.0030$0.002763,195
Ticker
OTC:AXIM
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
OTC
Currency
USD

What changed lately

Latest news

AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease

Oct 6, 2026

Closed $0.0035 (+2.9%) on Oct 6, 2026

Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids

Jan 29, 2026

Closed $0.015 (0.0%) on Jan 29, 2026

Issued by another party

AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor

Jan 20, 2026

Closed $0.0090 (0.0%) on Jan 20, 2026

AXIM Biotechnologies, Inc. Announces Exclusive Distribution Agreement With VisionPlus Corp. for TearScan(R) Lactoferrin and IgE Diagnostic Tests in South Korea

Oct 23, 2025

AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests

Oct 7, 2025

Axim Biotechnologies Files Pre-Submission With FDA for CLIA Waiver Pathway on Lactoferrin Point-of-Care Diagnostic Test

Jun 24, 2025

AXIM® Biotechnologies Receives Medical Device Manufacturing License

May 31, 2024

EQS-News: VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024

Mar 27, 2024

VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024

Mar 27, 2024

EQS-News: AXIM Biotechnologies Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation

Feb 20, 2024

All Axim Biotechnologies, Inc. news

Decks

Axim Biotechnologies, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
4 in the last 12 months · 185 in all · newest Oct 6, 2026 · oldest 2017
Decks
5 decks · latest January 2022

Log in to ask 6ix AI your own questions about Axim Biotechnologies, Inc.